Abstract
Cancer is a major public health concern and is one of the leading causes of death
worldwide. Cervical cancer is one of the most common types of cancer, affecting women
on a global scale. Infection caused by high-risk human papillomaviruses (HPVs),
especially type 16 and 18 are implicated in the aetiology of most cervical cancers.
Coupled with their involvement in cancer, these viruses can cause life-long debilitating
diseases that may be accompanied by a significant negative impact on quality of life.
High- risk HPV infections interfere with the molecular pathways that are responsible for
regulating epithelial differentiation as well as cell proliferation.
HPV onco-proteins E6 and E7 contribute towards cellular changes in HPV infected cells.
These facilitate the persistence of infection that might allow the progression of the lesions
towards cancer. E6 interacts physically with tumour suppressor protein p53 and prevents
its function; this activity will ultimately impede apoptosis. On the other hand, E7 binds to
retinoblastoma (Rb) protein and prevents the interaction of Rb with its natural target,
namely transcription factor E2F. Consequently the checkpoint that controls G1/S
transition becomes distorted, causing uncontrolled proliferative lesions. Once
proliferative lesions persist they can progress to high-grade ones and become an invasive
form of cervical cancer . It has been demonstrated that the presence of even minimal
amounts of HPV DNA are associated with an increased risk in the development of
cervical cancer. Given the importance of cervical cancer, to date, there has been no
satisfactory medical treatment for human papillomavirus related cervical cancer as most
of the developed treatments (e.g., surgical excision, chemotherapy, and cryotherapy) are
eventually accompanied by excessive tissue injury. Therefore, there is a continuing
demand for development of new strategies for treatment, which avoids tissue injury.
Herbal medicinal and biological studies have revealed that public interest in utilising
traditional remedies has greatly increased. Among various medically relevant plants, the
xiii
fig latex (Ficus carica), when applied to low risk human papillomavirus (HPV) related
skin warts and bovine papillomavirus (BPV) related warts, has shown potential as a
possible cure for the virus without inevitable tissue injury and remedial complications.
Fig latex also reportedly offers various therapeutic effects such as anti-Herpes Simplex
Virus (HSV)-1, anti-bacterial activity and anthelmintic. As a consequence we
investigated the biological activity of the Ficus carica latex on high risk HPV related
cervical cancer. Herein, we show that Ficus carica latex effectively inhibits growth of
HPV positive cervical cancer cells (CaSki and HeLa), without a cytotoxic effect on HPV
and cancer-free human immortalised keratinocyte (HaCaT) cell line. The latex presents
anti-cancer effects by various mechanisms, including induction of apoptosis and
inhibition of cell transformation; colony formation, cell proliferation, migration and
invasion. In addition to its potent anti-cancer effects, the results obtained indicate that Fig
latex has profound influence on the deregulation of HPV oncoproteins (E6 and E7) and
HPV diagnostic marker protein (p16) and initiates the reactivation of Rb and p53 tumor
suppressor proteins. These findings provide insight into new therapeutic avenues against
HPV- associated cervical cancers.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy (PhD) |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Publication status | Accepted/In press - Nov 2019 |
| Externally published | Yes |
Bibliographical note
Physical Location: Online Only.Keywords
- Cancer studies
PhD type
- Standard route